Surfing the MASH Tsunami

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(1073)

S3-E48 - Review of Exciting Clinical Trial Press Releases

S3-E48 - Review of Exciting Clinical Trial Press Releases

Send us Fan Mail A recent string of press releases has presaged some of the most exciting, promising data of the last decade in NASH drug development. In this episode, Stephen Harrison reviews recent...

6 Loka 202259min

S3-E47.6 - From the Vault: Most important Story of Summer: Ian Rowe says “FDA ELF Approval”

S3-E47.6 - From the Vault: Most important Story of Summer: Ian Rowe says “FDA ELF Approval”

Send us Fan Mail In this episode From the Vault, Surfers Roger Green and Louise Campbell are joined by Professor Ian Rowe to discuss the implications of the FDA approval of the ELF test. For Ian, the ...

2 Loka 202223min

S3-E47.5 - Combination NIT Biomarkers and Developing a Viable System for Treating Patients

S3-E47.5 - Combination NIT Biomarkers and Developing a Viable System for Treating Patients

Send us Fan Mail After a month of major Fatty Liver medical meetings, Jörn Schattenberg, Louise Campbell and Roger Green explore emerging stories that will shape the next 6-12 months in Fatty Liver di...

2 Loka 202211min

S3-E47.4 - Potential Bottlenecks in Getting Drugs to NAFLD Patients

S3-E47.4 - Potential Bottlenecks in Getting Drugs to NAFLD Patients

Send us Fan Mail After a month of major Fatty Liver medical meetings, Jörn Schattenberg, Louise Campbell and Roger Green explore emerging stories that will shape the next 6-12 months in Fatty Liver di...

2 Loka 202212min

S3-E47.3 - Implications of Positive Drug Trials and Eventual Approvals on NAFLD Treatment

S3-E47.3 - Implications of Positive Drug Trials and Eventual Approvals on NAFLD Treatment

Send us Fan Mail After a month of major Fatty Liver medical meetings, Jörn Schattenberg, Louise Campbell and Roger Green explore emerging stories that will shape the next 6-12 months in Fatty Liver di...

1 Loka 202212min

S3-E47.2 - The role of multiple biomarker tests in the diagnostic process

S3-E47.2 - The role of multiple biomarker tests in the diagnostic process

Send us Fan Mail After a month of major Fatty Liver medical meetings, Jörn Schattenberg, Louise Campbell and Roger Green explore emerging stories that will shape the next 6-12 months in Fatty Liver di...

1 Loka 202212min

S3-E47.1 - Collaborative energies shifting the force around Fatty Liver

S3-E47.1 - Collaborative energies shifting the force around Fatty Liver

Send us Fan Mail After a month of major Fatty Liver medical meetings, Jörn Schattenberg, Louise Campbell and Roger Green explore emerging stories that will shape the next 6-12 months in Fatty Liver di...

1 Loka 202212min

S3-E47 - What does the next year hold for the NAFLD-metabolic disease link?

S3-E47 - What does the next year hold for the NAFLD-metabolic disease link?

Send us Fan Mail The last month has witnessed several major Fatty Liver conferences and others that touch on NAFLD in the context of metabolic disease. One common theme has been the need for different...

29 Syys 202257min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
utelias-mieli
mielipaivakirja
radio-antro
rss-hereilla
rss-poliisin-mieli
rss-astetta-parempi-elama-podcast
rss-ylistys-elaimille
docemilia
vinkista-vihia
filocast-filosofian-perusteet
menologeja-tutkimusmatka-vaihdevuosiin
rss-duodecim-lehti
rss-murremyytin-murtajat
rss-totuuden-liepeilla